In India, China and several other nations, Novo Nordisk is on the verge of losing patent protection for its blockbuster weight loss drug, opening the door for cheaper competing versions.
Source link
Trending
- Your Kids Asked the Artemis Astronauts Questions. They Answered.
- What Is Body Dysmorphic Disorder?
- Greenpeace Suffers Another Blow in Court Fight With Energy Transfer
- Hantavirus Vaccines and Treatments Are in the Pipeline
- Hantavirus Is Nothing Like Coronavirus, but It’s Bringing Some ‘Covid P.T.S.D.’
- There Are Ants in This Canadian Hospital. Again.
- U.F.O. Files Released by U.S. Shed Light on What the Government Knows
- Trump Plans to Fire F.D.A. Commissioner Marty Makary
Ozempic Is About to Go Generic in India, China and Canada
MOST. JESMIN AKTER
Hi , I am MOST JESMIN AKTER . I am Journalist , I am News Reporter of The MoorningTimes Online News Portal
Add A Comment
